This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of July 2024. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.
| Item | Value |
|---|---|
| Country | |
| Facebook page | broadinstitute |
| Website | http://www.broadinstitute.org/ |
| Twitter username | broadinstitute |
| Wikipedia page | https://en.wikipedia.org/wiki/Broad_Institute |
| Instagram username | broadinstitute |
| Cause area | Count | Median | Mean | Minimum | 10th percentile | 20th percentile | 30th percentile | 40th percentile | 50th percentile | 60th percentile | 70th percentile | 80th percentile | 90th percentile | Maximum |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall | 28 | 764,493 | 1,717,240 | -1,283 | 85,000 | 200,000 | 273,209 | 637,348 | 764,493 | 1,326,484 | 1,728,130 | 1,928,229 | 2,503,845 | 16,312,343 |
| Global health | 28 | 764,493 | 1,717,240 | -1,283 | 85,000 | 200,000 | 273,209 | 637,348 | 764,493 | 1,326,484 | 1,728,130 | 1,928,229 | 2,503,845 | 16,312,343 |
| Donor | Total | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation (filter this donee) | 48,082,728.17 | 500,000.00 | 1,191,926.11 | 504,954.00 | 3,427,475.06 | 3,456,259.00 | 19,770,476.00 | 200,000.00 | 6,972,563.00 | 8,123,914.00 | 3,935,161.00 |
| Total | 48,082,728.17 | 500,000.00 | 1,191,926.11 | 504,954.00 | 3,427,475.06 | 3,456,259.00 | 19,770,476.00 | 200,000.00 | 6,972,563.00 | 8,123,914.00 | 3,935,161.00 |
There are no documents associated with this donee.
Graph of top 10 donors (for donations with known year of donation) by amount, showing the timeframe of donations
| Donor | Amount (current USD) | Amount rank (out of 28) | Donation date | Cause area | URL | Influencer | Notes |
|---|---|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation | 500,000.00 | 19 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to aid drug discovery and vaccine development to accelerate the eradication of malaria; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | -1,282.89 | 28 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to obtain, and make immediately available, current and accurate Ebola virus genetic sequence to help ensure that up-to-date information is available to support the global efforts to develop or deploy diagnostics, therapeutics and vaccines for the current ; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 273,209.00 | 20 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to aid drug discovery and vaccine development to accelerate the eradication of malaria; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 920,000.00 | 13 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to discover and functionally characterize novel antibiotics using deep learning. Image-based phenoscaping and evaluation of omic cell context networks in bacteria. Investment start date: 10/26/2017 to end date: 12/31/2019. Grantee name: Broad Institute; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 252,477.00 | 21 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to identify novel/unique small molecules from the Broad Institute’s diversity-oriented synthesis (DOS) library that target the malaria parasite as well as ones that target the causative agent of tuberculosis; Aid type: Project-type interventions. Affected regions: South of Sahara|Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 252,477.00 | 21 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to identify novel/unique small molecules from the Broad Institute’s diversity-oriented synthesis (DOS) library that target the malaria parasite as well as ones that target the causative agent of tuberculosis; Aid type: Project-type interventions. Affected regions: South of Sahara|Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 637,348.02 | 17 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to identify protein biomarkers for future development into rapid diagnostic tests to distinguish bacterial pneumonia, viral pneumonia and malaria in children in rural Africa based on an inexpensive blood test; Aid type: Project-type interventions. Affected regions: Africa|South of Sahara. | |
| Bill and Melinda Gates Foundation | 612,353.98 | 18 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to identify protein biomarkers for future development into rapid diagnostic tests to distinguish bacterial pneumonia, viral pneumonia and malaria in children in rural Africa based on an inexpensive blood test; Aid type: Project-type interventions. Affected regions: Africa|South of Sahara. | |
| Bill and Melinda Gates Foundation | 1,326,484.00 | 12 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to aid drug discovery and vaccine development to accelerate the eradication of malaria; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | -48.94 | 27 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to better prioritize antimalarial drug candidates by identifying those compounds that inhibit the efficacy of drugs used to treat HIV and tuberculosis (TB) when administered to the same person using an in vitro human microliver model; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 851,338.00 | 14 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to obtain, and make immediately available, current and accurate Ebola virus genetic sequence to help ensure that up-to-date information is available to support the global efforts to develop or deploy diagnostics, therapeutics and vaccines for the current ; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,728,129.50 | 9 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to identify novel/unique small molecules from the Broad Institute’s diversity-oriented synthesis (DOS) library that target the malaria parasite as well as ones that target the causative agent of tuberculosis; Aid type: Project-type interventions. Affected regions: South of Sahara|Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,728,129.50 | 9 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to identify novel/unique small molecules from the Broad Institute’s diversity-oriented synthesis (DOS) library that target the malaria parasite as well as ones that target the causative agent of tuberculosis; Aid type: Project-type interventions. Affected regions: South of Sahara|Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 16,312,343.00 | 1 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to validate novel drug discovery tools to serve as a basis for a comprehensive chemigenomics program; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,774,128.00 | 8 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to aid drug discovery and vaccine development to accelerate the eradication of malaria; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 764,492.55 | 15 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to identify protein biomarkers for future development into rapid diagnostic tests to distinguish bacterial pneumonia, viral pneumonia and malaria in children in rural Africa based on an inexpensive blood test; Aid type: Project-type interventions. Affected regions: Africa|South of Sahara. | |
| Bill and Melinda Gates Foundation | 734,512.45 | 16 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to identify protein biomarkers for future development into rapid diagnostic tests to distinguish bacterial pneumonia, viral pneumonia and malaria in children in rural Africa based on an inexpensive blood test; Aid type: Project-type interventions. Affected regions: Africa|South of Sahara. | |
| Bill and Melinda Gates Foundation | 85,000.00 | 26 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to aid drug discovery and vaccine development to accelerate the eradication of malaria; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 24 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to better prioritize antimalarial drug candidates by identifying those compounds that inhibit the efficacy of drugs used to treat HIV and tuberculosis (TB) when administered to the same person using an in vitro human microliver model; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 200,000.00 | 23 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to aid drug discovery and vaccine development to accelerate the eradication of malaria; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 1,864,873.00 | 7 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | for P. falciparum genetic diversity: drug, vaccine, and disease severity applications; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 24 | Global health/Medical research | https://iatiregistry.org/publisher/bmgf | -- | to engineer bacterial viruses to deliver enzymes that can be designed to degrade the genome of pathogenic bacteria.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 2,503,845.00 | 3 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to identify novel/unique small molecules from the Broad Institute’s diversity-oriented synthesis (DOS) library that target the malaria parasite as well as ones that target the causative agent of tuberculosis; Aid type: Project-type interventions. Affected regions: South of Sahara|Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 2,503,845.00 | 3 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to identify novel/unique small molecules from the Broad Institute’s diversity-oriented synthesis (DOS) library that target the malaria parasite as well as ones that target the causative agent of tuberculosis; Aid type: Project-type interventions. Affected regions: South of Sahara|Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,535,508.00 | 11 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to aid drug discovery and vaccine development to accelerate the eradication of malaria; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 6,588,406.00 | 2 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | for P. falciparum genetic diversity: drug, vaccine, and disease severity applications; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 2,006,932.11 | 5 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to identify protein biomarkers for future development into rapid diagnostic tests to distinguish bacterial pneumonia, viral pneumonia and malaria in children in rural Africa based on an inexpensive blood test; Aid type: Project-type interventions. Affected regions: Africa|South of Sahara. | |
| Bill and Melinda Gates Foundation | 1,928,228.89 | 6 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to identify protein biomarkers for future development into rapid diagnostic tests to distinguish bacterial pneumonia, viral pneumonia and malaria in children in rural Africa based on an inexpensive blood test; Aid type: Project-type interventions. Affected regions: Africa|South of Sahara. |